184 related articles for article (PubMed ID: 23818683)
1. Pharmacology at work for cardio-oncology: ranolazine to treat early cardiotoxicity induced by antitumor drugs.
Minotti G
J Pharmacol Exp Ther; 2013 Sep; 346(3):343-9. PubMed ID: 23818683
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of Ranolazine versus Common Cardiovascular Drugs in Patients with Early Diastolic Dysfunction Induced by Anthracyclines or Nonanthracycline Chemotherapeutics: A Phase 2b Minitrial.
Minotti G; Menna P; Calabrese V; Greco C; Armento G; Annibali O; Marchesi F; Salvatorelli E; Reggiardo G
J Pharmacol Exp Ther; 2019 Aug; 370(2):197-205. PubMed ID: 31101682
[TBL] [Abstract][Full Text] [Related]
3. Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts--role of late sodium current and intracellular ion accumulation.
Sossalla S; Wagner S; Rasenack EC; Ruff H; Weber SL; Schöndube FA; Tirilomis T; Tenderich G; Hasenfuss G; Belardinelli L; Maier LS
J Mol Cell Cardiol; 2008 Jul; 45(1):32-43. PubMed ID: 18439620
[TBL] [Abstract][Full Text] [Related]
4. [Ranolazine--an additional anti-anginal drug].
Michels G; Kochanek M; Hoppe UC
Dtsch Med Wochenschr; 2010 Oct; 135(41):2037-40. PubMed ID: 20925013
[TBL] [Abstract][Full Text] [Related]
5. RAnoLazIne for the treatment of diastolic heart failure in patients with preserved ejection fraction: the RALI-DHF proof-of-concept study.
Maier LS; Layug B; Karwatowska-Prokopczuk E; Belardinelli L; Lee S; Sander J; Lang C; Wachter R; Edelmann F; Hasenfuss G; Jacobshagen C
JACC Heart Fail; 2013 Apr; 1(2):115-22. PubMed ID: 24621836
[TBL] [Abstract][Full Text] [Related]
6. Metabolic efficiency with ranolazine for less ischemia in non-ST elevation acute coronary syndromes (MERLIN TIMI-36) study.
Melloni C; Newby LK
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):9-16. PubMed ID: 18095903
[TBL] [Abstract][Full Text] [Related]
7. [Ranolazine in the prevention of anthracycline-related cardiotoxicity].
Corradi F; Paolini L; De Caterina R
G Ital Cardiol (Rome); 2013 Jun; 14(6):424-37. PubMed ID: 23748539
[TBL] [Abstract][Full Text] [Related]
8. The late Na+ current (INa) inhibitor ranolazine attenuates effects of palmitoyl-L-carnitine to increase late INa and cause ventricular diastolic dysfunction.
Wu Y; Song Y; Belardinelli L; Shryock JC
J Pharmacol Exp Ther; 2009 Aug; 330(2):550-7. PubMed ID: 19403851
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological foundations of cardio-oncology.
Minotti G; Salvatorelli E; Menna P
J Pharmacol Exp Ther; 2010 Jul; 334(1):2-8. PubMed ID: 20335321
[TBL] [Abstract][Full Text] [Related]
10. Ranolazine: a novel agent that improves dysfunctional sodium channels.
Pham DQ; Mehta M
Int J Clin Pract; 2007 May; 61(5):864-72. PubMed ID: 17493093
[TBL] [Abstract][Full Text] [Related]
11. Role of ranolazine in angina, heart failure, arrhythmias, and diabetes.
Sossalla S; Maier LS
Pharmacol Ther; 2012 Mar; 133(3):311-23. PubMed ID: 22133843
[TBL] [Abstract][Full Text] [Related]
12. Ranolazine for the management of coronary artery disease.
Cheng JW
Clin Ther; 2006 Dec; 28(12):1996-2007. PubMed ID: 17296457
[TBL] [Abstract][Full Text] [Related]
13. Ranolazine improves cardiac diastolic dysfunction through modulation of myofilament calcium sensitivity.
Lovelock JD; Monasky MM; Jeong EM; Lardin HA; Liu H; Patel BG; Taglieri DM; Gu L; Kumar P; Pokhrel N; Zeng D; Belardinelli L; Sorescu D; Solaro RJ; Dudley SC
Circ Res; 2012 Mar; 110(6):841-50. PubMed ID: 22343711
[TBL] [Abstract][Full Text] [Related]
14. Ranolazine: new paradigm for management of myocardial ischemia, myocardial dysfunction, and arrhythmias.
Stone PH
Cardiol Clin; 2008 Nov; 26(4):603-14. PubMed ID: 18929234
[TBL] [Abstract][Full Text] [Related]
15. Ranolazine improves diastolic function in spontaneously hypertensive rats.
Williams S; Pourrier M; McAfee D; Lin S; Fedida D
Am J Physiol Heart Circ Physiol; 2014 Mar; 306(6):H867-81. PubMed ID: 24464752
[TBL] [Abstract][Full Text] [Related]
16. A novel mechanism for the treatment of angina, arrhythmias, and diastolic dysfunction: inhibition of late I(Na) using ranolazine.
Maier LS
J Cardiovasc Pharmacol; 2009 Oct; 54(4):279-86. PubMed ID: 19333133
[TBL] [Abstract][Full Text] [Related]
17. Ranolazine: a new approach to treating an old problem.
Reddy BM; Weintraub HS; Schwartzbard AZ
Tex Heart Inst J; 2010; 37(6):641-7. PubMed ID: 21224931
[TBL] [Abstract][Full Text] [Related]
18. New treatment options for late Na current, arrhythmias, and diastolic dysfunction.
Maier LS
Curr Heart Fail Rep; 2012 Sep; 9(3):183-91. PubMed ID: 22767404
[TBL] [Abstract][Full Text] [Related]
19. Ranolazine for chronic stable angina.
Nash DT; Nash SD
Lancet; 2008 Oct; 372(9646):1335-41. PubMed ID: 18929905
[TBL] [Abstract][Full Text] [Related]
20. Ranolazine: clinical applications and therapeutic basis.
Hawwa N; Menon V
Am J Cardiovasc Drugs; 2013 Feb; 13(1):5-16. PubMed ID: 23335347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
